| Literature DB >> 28678204 |
Sung Hye Youn1, Joo Hee Kwon2, Jun Yin3, Le Thi Tam4, Hye Shin Ahn5, Soon Chul Myung6, Min Won Lee7.
Abstract
Quercus gilva Bume (QGB, family Fagaceae) is a tall evergreen oak species tree that grows in warm temperate regions in Korea, Japan, China and Taiwan. Quercus plants have long been the basis of traditional medicines. Their clinical benefits according to traditional medicine include relief of urolithiasis, tremors and inflammation. In the present study, the anti-urolithiasis activity including anti-inflammatory and anti-oxidative activities, of some phenolic compounds isolated from QGB were described. Seven compounds were isolated and identified as picraquassioside D (1), quercussioside (2), (+)-lyoniresinol-9'α-O-β-d-xylopyranoside (3), (+)-catechin (4), (-)-epicatechin (5), procyanidin B-3 (6), and procyanidin B-4 (7). Compounds 5-7 showed potent anti-oxidative and anti-inflammatory activities. These compounds were further tested for their inhibition of the gene expression of the inflammatory cytokines. The three compounds 5-7 showed dose-dependent inhibitory activities on gene expression of COX-2 and IL-1β. In vivo, urolithiasis was induced more effectively in an animal model of acute urolithiasis by the administration of QGB extract. These results indicate the potential of compounds from QGB in the treatment of urolithiasis.Entities:
Keywords: Quercus gilva Blume; anti-inflammation; anti-oxidation; anti-urolithiasis; polyphenol
Mesh:
Substances:
Year: 2017 PMID: 28678204 PMCID: PMC6152187 DOI: 10.3390/molecules22071121
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of QGB compounds 1–7.
IC50 values for DPPH radical scavenging activity from different parts of QG plants and from isolated compounds.
| Extract | IC50 (μg/mL) | Compound | IC50 (μM) |
|---|---|---|---|
| Leave | 19.15 ± 0.22 | >100 h | |
| Branch | 33.07 ± 0.34 | >100 g | |
| Bark | 10.58 ± 0.85 | 74.23 ± 0.39 f | |
| Wood | 16.14 ± 0.80 | 43.37 ± 0.57 e | |
| 6.04 ± 0.27 | 28.80 ± 1.02 d | ||
| 15.10 ± 0.34 b | |||
| 12.15 ± 0.18 a | |||
| 27.41 ± 1.28 c |
Values are expressed as mean ± S.D. of three determinations. Values bearing different superscripts (a–g) in same columns are significantly different (p < 0.05).
IC50 values for NBT/superoxide scavenging activity from different parts of QG plants and from isolated compounds.
| Extract | IC50 (μg/mL) | Compound | IC50 (μM) |
|---|---|---|---|
| Leave | 7.50 ± 0.47 | >100 d | |
| Branch | 20.07 ± 2.24 | >100 c | |
| Bark | 4.43 ± 0.16 | >100 b | |
| Wood | 7.07 ± 0.98 | 15.44 ± 1.44 a | |
| Allopurinol | 1.08 ± 0.22 | 11.01 ± 0.16 a | |
| 7.21 ± 0.38 a | |||
| 8.67 ± 0.22 a | |||
| Allopurinol | 5.43 ± 0.40 a |
Values are expressed as mean ± S.D. of three determinations. Values bearing different superscripts (a–d) in same columns are significantly different (p < 0.05 NBT/superoxide scavenging activity).
IC50 values of QGB compounds 1–7 on inhibition of NO production in RAW 264.7 macrophages.
| Sample | NO Production Inhibitory Activity (μM) |
|---|---|
| >100 f | |
| 63.99 ± 12.53 d | |
| 9.14 ± 0.45 b | |
| >100 e | |
| 14.47 ± 5.29 c | |
| 7.07 ± 0.40 b | |
| 1.44 ± 1.03 a | |
| 2.72± 0.80 a |
Values are expressed as mean ± S.D. of three determinations. Values bearing different superscripts (a–f) in same columns are significantly different (p < 0.05).
Figure 2Inhibition of mRNA expression of iNOS, COX-2 and IL-1β by phenolic compounds 5–7 from QGB. Activities were determined by RT-PCR at least three times. Concentration of LPS was 1 μM. Values bearing different superscripts in same columns are significantly different (*: p < 0.05, **: p < 0.01, ***: p < 0.001) (n = 3).
Stone values of X-rats kidney tissue with ethylene glycol (EG) concentration.
| Group No. | Treatment | Upper Pole | Mid Pole | Lower Pole | Average |
|---|---|---|---|---|---|
| Group 2 | 0.2% EG (acute) | 35 | 57 | 38 | 44.33 a |
| Group 3 | 0.4% EG (acute) | 80 | 112.17 | 90 | 90.05 b |
| Group 5 | 0.2% EG (chronic) | 43.5 | 46.5 | 38 | 42.67 a |
| Group 6 | 0.4% EG (chronic) | 70.92 | 74.67 | 70.92 | 72.16 a,b |
Group 2: No. 7–11 (0.2% EG for 2 weeks) a; Group 3: No. 12–18 (0.4% EG for 2 weeks) b; Group 5: No. 25–30 (0.2% EG for 4 weeks) a; Group 6: No. 31–35 (0.4% EG for 4 weeks) a,b; Values bearing different superscripts (a, b) in same columns are significantly different (p < 0.01).
Stone values of X-rats kidney section treated ethylene glycol (EG) and drug treatment.
| Group No. | Treatment | Upper Pole | Mid Pole | Lower Pole | Average |
|---|---|---|---|---|---|
| B | EG | 111.83 | 92.67 | 105.33 | 119.33 |
| C | EG + low drug | 5 | 4.67 | 2 | 2.33 * |
| D | EG + high drug | 14 | 7.5 | 15 | 12.17 * |
Group B: No. 7–12 (control: 0.4% of EG); Group C: No. 13–18 (EG + low dose drug for 2 weeks) *; Group D: No. 19–24 (EG + high dose drug for 2 weeks) *; The p values of mark [*] was less than 0.001.
Figure 3Representative microscopic images of stained of kidney sections from X-rats. The panels are as follows: blank (normal) (A); control (0.4% of ethylene glycol) (B); EG + low dose of drug (C); EG + high dose of drug (D). Arrows mean stones of kidney from X-rat. All panels are sections viewed by polarized light microscope (100×) after Hematoxylin and Eosin staining and under light microscope after Pizzolato’s staining (40×), respectively.
Figure 4Extraction and separation processes of active compounds from bark of Quercus gilva Blume.
Experimental design of urolithiasis induction and anti-urolithiasis activity in the in vivo.
| (A) | ||
|---|---|---|
| Group No. | Day | Treatment |
| 1 | 2 weeks | Normal Control (sterilized water) |
| 2 | 0.2% EG, as acute model | |
| 3 | 0.4% EG, as acute model | |
| 4 | 4 weeks | Normal Control (sterilized water) |
| 5 | 0.2% EG, as chronic model | |
| 6 | 0.4% EG, as chronic model | |
| ( | ||
| A | 2 weeks | Normal Control (saline) |
| B | Control (0.4% EG) | |
| C | 0.4% EG + low drug | |
| D | 0.4% EG + high drug | |